Mouse Anti-CEA Recombinant Antibody (clone H310A/H435Q); scFv Fragment (CAT#: HPAB-0348CQ)

This product is a recombinant human antibody that can bind to human CEA with high affinity.

Specific Inquiry Online Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Competition ELISA binding assay.

Figure 1 Competition ELISA binding assay.

Plates were coated with recombinant NA-3 antigen. Increasing concentrations of wild-type, I253A, and H310A/H435Q unlabeled fragments were used to compete out the biotinylated intact, cT84.66 anti-CEA monoclonal antibody.

Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., ... & Williams, L. E. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer research, 65(2), 622-631.

Figure 2 Blood activity curves.

Figure 2 Blood activity curves.

Dual biodistribution studies with ¹²⁵I- and ¹³¹I-labeled scFv-Fcs.

Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., ... & Williams, L. E. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer research, 65(2), 622-631.

FuncS

Figure 3 Coronal microPET images of five constructs in representative individual athymic mice bearing LS174T xenografts (left shoulder) and C6 (right shoulder, except D) at three different time points.

Figure 3 Coronal microPET images of five constructs in representative individual athymic mice bearing LS174T xenografts (left shoulder) and C6 (right shoulder, except D) at three different time points.

Arrow, CEA-positive tumors. Following the imaging studies, tumors were dissected, weighed, and counted in a gamma counter. A, wild-type 42.5% ID/g, 185 mg LS174T tumor weight at 48 hours post injection; B, H435Q 10.6% ID/g, 64 mg at 123 hours; C, I253A 13.7% ID/g, 216 mg at 50 hours; D, H310A 10.6% ID/g, 174 mg at 53 hours; and E, H310A/H435Q 7.3% ID/g, 80 mg at 55 hours.

Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., ... & Williams, L. E. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer research, 65(2), 622-631.

FuncS

Figure 4 A, ratios derived from the PET data comparing CEA-positive tumor-to-background levels of ¹²⁴I activity.

Figure 4 A, ratios derived from the PET data comparing CEA-positive tumor-to-background levels of ¹²⁴I activity.

Early (3–4 hours), intermediate (16–18 hours), and late (48–90 hours) time points. B, ratios derived from the PET data comparing CEA-positive tumor-to-soft tissue levels of ¹²⁴I activity.

Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., ... & Williams, L. E. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer research, 65(2), 622-631.

Figure 5 ELISA measurements of pH-dependent binding of mFcRn and hFcRn to the scFv-Fc variants.

Figure 5 ELISA measurements of pH-dependent binding of mFcRn and hFcRn to the scFv-Fc variants.

Binding responses of mFcRn to titrated amounts of WT, I253A, H310A, H435R, H435Q, and H310A/H435Q at pH 6.0 (A) and pH 7.4 (B), respectively. Binding of hFcRn to titrated amounts of WT, I253A, H310A, H435R, H435Q, and H310A/H435Q at pH 6.0 (C) and pH 7.4 (D). The numbers given represent the mean of triplicates.

Andersen, J. T., Foss, S., Kenanova, V. E., Olafsen, T., Leikfoss, I. S., Roopenian, D. C., ... & Sandlie, I. (2012). Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. Journal of Biological Chemistry, 287(27), 22927-22937.

Figure 6 SPR binding profiles of anti-CEA scFv-Fc variants to immobilized mFcRn.

Figure 6 SPR binding profiles of anti-CEA scFv-Fc variants to immobilized mFcRn.

Representative sensorgram overlays obtained with 0.5 μm of the anti-CEA ScFv-Fc variants injected over a flow cell coupled with mFcRn (∼900 RU) at a flow rate of 50 μL/min (pH 6.0 and 7.4). A, WT; B, I253A; C, H310A; D, H435R; E, H435Q; and F, H310A/H435Q. The sensorgrams were zero-adjusted and reference cell data subtracted.

Andersen, J. T., Foss, S., Kenanova, V. E., Olafsen, T., Leikfoss, I. S., Roopenian, D. C., ... & Sandlie, I. (2012). Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. Journal of Biological Chemistry, 287(27), 22927-22937.

Figure 7 Blood activity curves of ¹²³I-labeled scFv-Fc fragments in hFcRn transgenic mice.

Figure 7 Blood activity curves of ¹²³I-labeled scFv-Fc fragments in hFcRn transgenic mice.

Mice were injected with 96–130 μCi of ¹²³I-labeled scFv-Fc proteins (30 μg of labeled protein/mouse) under anesthesia. Blood samples were collected from the tail immediately after injection (0-h time point) and at time points 2, 4, 6, 12, 24, 48, and 72 h post-injection. Blood activity was determined using a Wallac WIZARD automatic gamma. The percentage of injected dose/g (% ID/g) was calculated. Each group represents four mice. Logarithmic scale, S.E. was used to measure variability.

Andersen, J. T., Foss, S., Kenanova, V. E., Olafsen, T., Leikfoss, I. S., Roopenian, D. C., ... & Sandlie, I. (2012). Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. Journal of Biological Chemistry, 287(27), 22927-22937.

Figure 8 Blood clearance curves of ¹²³I-labeled scFv-Fc variants in WT BALB/c mice and hFcRn transgenic mice.

Figure 8 Blood clearance curves of ¹²³I-labeled scFv-Fc variants in WT BALB/c mice and hFcRn transgenic mice.

Blood samples were collected from the tail immediately after injection (0-h time point) and at time points 2, 4, 6, 12, 24, 48, and 72 h post-injection. Blood activity was determined using a Wallac WIZARD automatic gamma. The percentage of injected dose per gram (% ID/g) was calculated. Each group represents four mice. Logarithmic scale, S.E. was used to measure variability.

Andersen, J. T., Foss, S., Kenanova, V. E., Olafsen, T., Leikfoss, I. S., Roopenian, D. C., ... & Sandlie, I. (2012). Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. Journal of Biological Chemistry, 287(27), 22927-22937.


Specifications

  • Host Species
  • Mouse
  • Type
  • Mouse scFv
  • Specificity
  • Human CEA
  • Species Reactivity
  • Human
  • Clone
  • H310A/H435Q
  • Applications
  • ELISA, WB, FuncS

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been tested for use in Enzyme-linked Immunosorbent Assay and Functional Assay. Please see the Published Data for further information.

Target

  • Alternative Names
  • CEA; Carcinoembryonic antigen

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CEA"

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-0348CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare